Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist
dc.contributor.author | You, Haitao | |
dc.contributor.author | Gadotti, Vinícius Maria | |
dc.contributor.author | Petrov, Ravil R. | |
dc.contributor.author | Berger, N. Daniel | |
dc.contributor.author | Diaz, Philippe J. | |
dc.contributor.author | Zamponi, Gerald W. | |
dc.date.accessioned | 2018-05-28T17:45:24Z | |
dc.date.available | 2018-05-28T17:45:24Z | |
dc.date.issued | 2013-07-01 | |
dc.description.abstract | Cannabinoid receptors and T-type calcium channels are potential targets for treating pain. Here we report on the design, synthesis and analgesic properties of a new mixed cannabinoid/T-type channel ligand, NMP-181. | en_US |
dc.description.sponsorship | Sponsored by the Open Access Authors Fund | en_US |
dc.identifier.citation | Gadotti, V. M., You, H., Petrov, R. R., Berger, N. D., Diaz, P., & Zamponi, G. W. (2013). Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist. Molecular Pain, 9(1), 32. https://doi.org/10.1186/1744-8069-9-32 | en_US |
dc.identifier.doi | http://dx.doi.org/10.1186/1744-8069-9-32 | en_US |
dc.identifier.uri | http://hdl.handle.net/1880/106693 | |
dc.identifier.uri | https://doi.org/10.11575/PRISM/43843 | |
dc.language.iso | en | en_US |
dc.publisher | BioMed Central Ltd. | en_US |
dc.publisher.department | Physiology & Pharmacology | en_US |
dc.publisher.faculty | Cumming School of Medicine | en_US |
dc.publisher.institution | University of Calgary | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | en_US |
dc.title | Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist | en_US |
dc.type | unknown |